Ciba Specialty Chemicals Corporation

Vesifact Ag

Siniq Gmbh

Roche Consumer Health (worldwide) Sa

Andreas Supersaxo

Hans Georg Weder

Dietmar Hüglin

Joachim Röding

Marc Antoine Weder

Juerg Schmid

Subject of the invention is a composition comprising: (a) at least one film-forming polymer, which does not comprise silicon, (b) at least one organic UV filter, and (c) at least one organic solvent, wherein the composition is liquid at 20&#xb0; C., wherein components (a) and (b) are dissolved in solvent (c), and wherein the ratio of the total amounts of organic UV filters (b) to film-forming polymers (a) is below 6.5. The invention also relates to compositions for therapy, uses of the composition, devices and methods.

Composition for covering and protecting scars

The invention relates to compositions in the form of microemulsion preconcentrates that contain (a) a mixture that consists of a medium-chain triglyceride and an omega-9 fatty acid and/or an omega-6 fatty acid; and (b) a surface-active component that contains a polyoxethylene tenside. When contacted with water or with an aqueous medium these microemulsion preconcentrates form microemulsions. The microemulsions of the O/W type have an average particle size below 150 nm, preferably below 100 nm. The inventive microemulsion preconcentrates and microemulsions are suitable for use as vehicles for substances, namely active agents, that are hardly soluble in water, but soluble in components (a) and/or (b). In the aqueous phase, said microemulsions may contain water-soluble substances.

Microemulsion preconcentrate, microemulsion and use thereof

A nanodispersion comprises The nanodispersions prepared according to this invention are suitable as transport vehicles for pharmaceutical active agents.

Use of nanodispersions in pharmaceutical end formulations

A description is given of the use of a nanodispersion, which comprises The nanodispersions used according to this invention can be easily prepared and are suitable as carrier systems for a very wide range of cosmetic active agents and oil-soluble dyes.

Use of nanodispersions in cosmetic end formulations

A description is given of the use of a nanodispersion, which comprises The nanodispersions used according to this invention are suitable as transport vehicles for pharmaceutical active agents.

The present invention relates to a novel pharmaceutical formulation for the topical application of drugs, particularly non-steroidal anti-inflammatory drugs (NSAID's), comprising a therapeutically effective amount of a drug, sodium phosphate buffer, and, optionally, an alcoholic solvent. It has been found that by the addition of sodium phosphate buffer to such formulations, the permeation of the NSAID can be significantly improved.

Growing community of inventors

Baar, Switzerland

Andreas Supersaxo